Schmidt Vanessa F, Olivieri Martin, Häberle Beate, Masthoff Max, Deniz Sinan, Sporns Peter B, Wohlgemuth Walter A, Wildgruber Moritz
Department of Radiology, Ludwig Maximilian University Hospital, Munich, München, Germany.
Paediatric Thrombosis and Haemostasis Unit, Dr. von Hauner Children's Hospital Munich, Ludwig Maximilian University, Munich, Germany.
Hamostaseologie. 2022 Apr;42(2):131-141. doi: 10.1055/a-1728-5686. Epub 2022 Mar 9.
Extracranial vascular malformations vary greatly and belong to the complex field of orphan diseases and can involve all segments of the vascular tree: arteries, capillaries, and veins, and similarly the lymphatic system. The classification according to the International Society for the Study of Vascular Anomalies (ISSVA) represents an important guidance for selecting appropriate therapy. Although many of the principles of endovascular treatment, including image-guided sclerotherapy and embolization, are similar in adult and pediatric practice, there are some distinct differences regarding the treatment of vascular malformations of children. Thus, it is crucial to involve longer-term plan about managing these chronic diseases and their impact on a growing child. This review provides a detailed overview over the clinical presentation of venous, lymphatic, and arteriovenous malformations in children and emphasizes the specifics of their interventional treatment options, including distinct pediatric dose limitations and procedure-related side effects.
颅外血管畸形差异极大,属于罕见病这一复杂领域,可累及血管树的所有节段:动脉、毛细血管和静脉,淋巴系统亦是如此。国际血管畸形研究学会(ISSVA)的分类是选择合适治疗方法的重要指南。尽管血管内治疗的许多原则,包括影像引导下硬化治疗和栓塞,在成人和儿科实践中相似,但儿童血管畸形的治疗存在一些明显差异。因此,制定关于管理这些慢性病及其对成长中儿童影响的长期计划至关重要。本综述详细概述了儿童静脉、淋巴和动静脉畸形的临床表现,并强调了其介入治疗选择的特点,包括独特的儿科剂量限制和与手术相关的副作用。